SEARCH
Will DGCI ban on drug ingredients from China hurt the Pharma industry?
Mint
2018-02-16
Views
1
Description
Share / Embed
Download This Video
Report
The ban on the import of APIs from China may lead to possible shortages of antibiotics, and anti-
diabetes, anti-psychotic and antacid drugs, say pharma lobby groups
Subscribe Now For Latest Updates- https://tinyurl.com/lbw8nze
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://dailytv.net//embed/x6ev2d6" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
02:56
Some Unique Ingredients
03:12
Pharma industry to post 15% growth in profit
02:15
Reporter's Notebook | Sun Pharma eyes Swedish drug maker Meda
00:49
Note ban hits Rs20 trillion trafficking industry
03:06
NGT bans ‘Chinese manjha’ for kite-flying
00:00
Transformation Agenda 2020 by Mint and Danfoss : India's climate imperatives
00:00
Transformation Agenda 2020 : Farm to Fork - Challenges and Opportunities for India
00:00
Digitalist Forum with MINT & SAP
00:00
Transformation Agenda 2020 : India's changing urban landscape
03:14
Interview: Manipur's, Chief Electoral Officer, P.C. Lawkunga
02:23
Closing Bell
03:09
Deals Space